Caffeic Acid Phenethyl Ester

Caffeic Acid Phenethyl Ester

SCHEMBL93649

O=C(C=Cc1ccc(O)c(O)c1)OCCc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 5/20 1.00
AKR1B1 P15121 5/20 1.00
TTR P02766 5/20 1.00
APP P05067 5/20 1.00
CYP3A4 P08684 2/20 1.00
ALOX15 P16050 2/20 1.00
ALOX12 P18054 2/20 1.00
MAPK1 P28482 2/20 1.00
HSD17B10 Q99714 2/20 1.00
ALOX5 P09917 2/20 1.00
KDM4E B2RXH2 1/20 1.00
MEN1 O00255 1/20 1.00
GMNN O75496 1/20 1.00
ALDH1A1 P00352 1/20 1.00
EGFR P00533 1/20 1.00
LMNA P02545 1/20 1.00
ESR1 P03372 1/20 1.00
ERBB2 P04626 1/20 1.00
LCK P06239 1/20 1.00
FYN P06241 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Caffeic Acid Phenethyl Ester SCHEMBL28294426 1.00 AKR1B10 (1.00) AKR1B10AKR1B1TTRAPPCYP3A4
Caffeic Acid Phenethyl Ester SCHEMBL490546 1.00 AKR1B10 (1.00) AKR1B10AKR1B1TTRAPPCYP3A4
Caffeic Acid Phenethyl Ester SCHEMBL30070826 1.00 AKR1B10 (1.00) AKR1B10AKR1B1TTRAPPCYP3A4
Caffeic Acid Phenethyl Ester SCHEMBL30695557 0.99 TTR (0.97) AKR1B10AKR1B1TTRAPPCYP3A4
Caffeic Acid Phenethyl Ester SCHEMBL38666014 0.96 TTR (0.93) AKR1B10AKR1B1TTRAPPCYP3A4
Caffeic Acid Phenethyl Ester SCHEMBL15378852 0.95 APP (0.90) AKR1B10AKR1B1TTRAPPCYP3A4
SCHEMBL2602741 0.92 APP (0.85) AKR1B10AKR1B1TTRAPPCYP3A4
SCHEMBL20604716 0.91 APP (0.83) AKR1B10AKR1B1TTRAPPCYP3A4
SCHEMBL19359013 0.90 APP (0.81) AKR1B10AKR1B1TTRAPPCYP3A4
SCHEMBL20604718 0.90 APP (0.81) AKR1B10AKR1B1TTRAPPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3944 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080518-A High-aging-resistance vinyl elastomer material and preparation method thereof 2026-05-26 CN claimed
EP-3841097-B1 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) 2026-05-20 EP claimed
CN-122056924-A Calcium alginate microsphere containing chitosan oligosaccharide coated bifidobacterium and caffeic acid phenethyl ester-loaded nano enzyme and preparation method thereof 重庆医科大学 2026-05-19 CN claimed
WO-2026099270-A1 BIODEGRADABLE UV ABSORBERS AND USES THEREOF II BASF SE (DE) 2026-05-15 WO claimed
CN-122005532-A Application of caffeic acid phenethyl ester in preparation of ribosomal large subunit protein L1 targeted inhibitor 浙江大学 2026-05-12 CN claimed
WO-2025242885-A1 SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF BASF SE (DE) 2025-11-27 WO claimed
WO-2025242892-A1 SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF BASF SE (DE) 2025-11-27 WO claimed
WO-2025242899-A1 SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF BASF SE (DE) 2025-11-27 WO claimed
WO-2025242884-A1 SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF BASF SE (DE) 2025-11-27 WO claimed
WO-2025235593-A1 TREATMENT FOR OBSTRUCTIVE SLEEP APNEA-ASSOCIATED ATHEROSCLEROSIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-13 WO claimed
EP-1109528-A1 SELF-TANNING COMPOSITIONS CONTAINING DHA AND PROPOLIS EXTRACT Color Access, Inc. (US) 2001-06-27 EP claimed
US-6221578-B1 DETERMINING THE PHENOTYPIC DRUG SENSITIVITY OF INDIVIDUAL HIV STRAINS IN A PATIENT TO INHIBITORS OF TWO ENZYMES ENCODED BY THE POL GENE OF HIV, AND SELECTING A DIFFERENT INHIBITOR WHEN THE SUSCEPTIBILITY OF THE ORIGINAL INHIBITOR DECREASES VIRCO N.V. (BE) 2001-04-24 US claimed
WO-2001003665-A1 SELF-TANNING COMPOSITIONS CONTAINING DHA AND PROPOLIS EXTRACT COLOR ACCESS, INC. (US) 2001-01-18 WO claimed
US-6171605-B1 INCREASING RED, DECREASING YELLOW COLOR ACCESS, INC. 2001-01-09 US claimed
US-5981583-A Inhibition of nuclear transcription factor NF-κB by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin RESEARCH DEVELOPMENT FOUNDATION (US) 1999-11-09 US claimed
EP-0770143-A4 METHOD TO IDENTIFY TUMOR SUPPRESSOR GENES UNIV COLUMBIA (US) 1999-09-01 EP claimed
EP-0877937-A1 METHOD OF MANAGING THE CHEMOTHERAPY OF PATIENTS WHO ARE HIV POSITIVE BASED ON THE PHENOTYPIC DRUG SENSITIVITY OF HUMAN HIV STRAINS VIRCO N.V. (BE) 1998-11-18 EP claimed
WO-1997027480-A1 METHOD OF MANAGING THE CHEMOTHERAPY OF PATIENTS WHO ARE HIV POSITIVE BASED ON THE PHENOTYPIC DRUG SENSITIVITY OF HUMAN HIV STRAINS VIRCO N.V. (BE) 1997-07-31 WO claimed
EP-0770143-A1 METHOD TO IDENTIFY TUMOR SUPPRESSOR GENES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1997-05-02 EP claimed
WO-1995034680-A1 METHOD TO IDENTIFY TUMOR SUPPRESSOR GENES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1995-12-21 WO claimed